A conjugate vaccination is a form of vaccine that uses a carrier to combine a weak antigen with a strong antigen to boost protection. Vaccines work by inducing an immune response to an antigen, which helps to prevent disease. The combination vaccination is used to stimulate the immune system to respond to the weak antigen, resulting in a greater immune response to the weak antigen. The Hib conjugate vaccine is the most widely used conjugate vaccination. Streptococcus pneumonia and Neisseria meningitides, both of which are conjugated to protein carriers like those used in the Hib conjugate vaccine, are two more pathogens that are combined in a conjugate vaccine to promote an immune response.
Read more @ https://bit.ly/32yuvaG
Source:
https://www.coherentmarketinsights.com/market-insight/conjugate-vaccine-market-2697
